Free Trial
→ Buffett's Final Warning: 'The Dollar Is Going to Hell' (From Decentralized Masters) (Ad)tc pixel
NASDAQ:ELAB

PMGC Q3 2025 Earnings Results & Report

PMGC logo
$2.90 -0.07 (-2.49%)
As of 12:21 PM Eastern
This is a fair market value price provided by Massive. Learn more.

PMGC reported Q3 2025 earnings on November 14, 2025. The company reported EPS of -$1,188.00, while revenue was $0.29 million.

Research:ProfileEarnings HistoryForecast

Earnings Announcement Details

Quarter
Q3 2025
Report Date
Time
Before Market Opens

PMGC EPS Results

Actual EPS
-$1,188.00
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

PMGC Revenue Results

Actual Revenue
$0.29 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

PMGC Q3 2025 Earnings FAQ

PMGC (NASDAQ:ELAB) reported earnings of -$1,188.00 per share for Q3 2025. The report was announced on Friday, November 14, 2025.

PMGC reported revenue of $0.29 million for Q3 2025.

PMGC Earnings Headlines

PMGC (NASDAQ:ELAB) Shares Down 1.6% - Here's What Happened
October 10, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31104485
PMGC Holdings Inc. Announces DBA as NorthStrive Holdings, Inc., Trademark License Agreement, and Website Update
October 8, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/10/08/3377452/0/en/pmgc-holdings-inc-announces-dba-as-northstrive-holdings-inc-trademark-license-agreement-and-website-update.html
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel
October 15 at 1:00 AM  |  InvestorPlace (Ad)
PMGC Holdings (Nasdaq: ELAB) Announces Completion of $100 Million SPAC IPO, Launching NorthStrive Acquisition Corp. I (Nasdaq: NSAI) as First in Planned SPAC Sponsorship ...
October 1, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/pmgc-holdings-nasdaq-elab-announces-completion-of-100-million-spac-ipo-launching-northstrive-acquisition-corp-i-nasdaq-nsai-as-first-in-planned-spac-sponsorship-franchise-to-expand-m-a-1036589157
PMGC Holdings (Nasdaq: ELAB) Announces Completion of $100 Million SPAC IPO, Launching NorthStrive Acquisition Corp. I (Nasdaq: NSAI) as First in Planned SPAC Sponsorship Franchise to Expand M&A Strategy
October 1, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/10/01/3372840/0/en/pmgc-holdings-nasdaq-elab-announces-completion-of-100-million-spac-ipo-launching-northstrive-acquisition-corp-i-nasdaq-nsai-as-first-in-planned-spac-sponsorship-franchise-to-expand.html
PMGC Subsidiary NorthStrive Biosciences Engages Charles River Laboratories for Analytical Characterization of EL-22 and EL-32 Programs
September 29, 2026  |  quiverquant.comQ
See More PMGC Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like PMGC? Sign up for Earnings360's daily newsletter to receive timely earnings updates on PMGC and other key companies, straight to your email.

About PMGC

Elevai Labs, Inc., formerly known as PMGC (NASDAQ:ELAB) Holdings, Inc., is a biotechnology and medical aesthetics company focused on developing and commercializing innovative skincare products and aesthetic treatments. The company combines biotechnology, regenerative medicine and cosmetic science to address skin health, rejuvenation and related aesthetic needs.

Elevai Labs’ product development activities include topical skincare formulations and professional-use products designed for aesthetic providers. Its offerings are intended to support procedures and treatments addressing concerns such as skin aging, texture and overall appearance. The company has also described a proprietary platform for developing and manufacturing aesthetic products, including formulations based on regenerative and extracellular vesicle technologies.

Elevai Labs markets its products primarily through medical aesthetics and skincare channels, including physicians, clinics and other professional providers. The company is headquartered in California and has focused on expanding its presence in the U.S. aesthetics market. As a development-stage company, its product portfolio and commercial strategy may continue to evolve.

View PMGC Profile
Earnings Tools